Clin2
NCT06148311Possibly a fitEnrolling by invitation

Dexmedetomidine film for autonomic crises in Familial Dysautonomia

Familial Dysautonomia

Treatments studied

Part of Brain & nervous system, Genetic & congenital clinical trials.

This study tests a new dissolvable film containing dexmedetomidine (a medicine that calms overactive stress responses) for people with Familial Dysautonomia who experience sudden episodes called autonomic crises. It aims to treat these crises at home without needing a hospital visit.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
15 people
Ages
16 years to 80 years
Study type
Interventional

Who can take part

  • You must have a confirmed genetic diagnosis of Familial Dysautonomia.
  • You have had at least one autonomic crisis (episode of symptoms like high blood pressure, rapid heart rate, or nausea) in the past year.
  • You are 16 years old or older.
  • You have a caregiver who can talk with the doctors and help you follow the study plan.
  • You are willing to use birth control (condoms) if you are sexually active and could become pregnant or get someone pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04824144Recruiting· Phase 1/Phase 2
Dexmedetomidine for agitation in palliative care delirium

This trial tests whether dexmedetomidine can help calm agitation caused by delirium in adults receiving palliative (comfort-focused) care. It may help reduce restlessness and distress when standard approaches may not be enough.

Calgary, Alberta
NCT07542990Not yet recruiting· Phase 3
Dexmedetomidine for sedation in children on breathing machines

This study tests whether a sedative medication called dexmedetomidine can reduce confusion and delirium in children who need mechanical ventilation (breathing machines) in the intensive care unit. Researchers want to see if it works better and safer than standard sedatives.

Angers
NCT07550881Recruiting· Phase 2
Intranasal Dexmedetomidine for Sudden Anxiety in Adults

This study tests whether a medication called dexmedetomidine, given as a nasal spray, can quickly relieve sudden anxiety. The goal is to see if this approach works better or faster than current treatments for acute anxiety episodes.

Shanghai, Shanghai Municipality
NCT07493785Not yet recruiting· Phase 2/Phase 3
Dexmedetomidine for premature babies on a breathing machine

This trial tests a medication called dexmedetomidine to help keep premature babies calm and comfortable while on a breathing machine. It may reduce the need for stronger sedatives and improve recovery.

Brest
NCT06752616Recruiting· Phase 2/Phase 3
Study on calming severe agitation in psychiatric emergency rooms

This trial tests two different medications to quickly calm severe agitation in people admitted to a psychiatric emergency room. You may be able to join if you are extremely agitated and need urgent medication to help you settle down.

Copenhagen N
NCT06082856Recruiting
Dexmedetomidine for heart stability during outpatient surgery

This trial tests whether a drug called dexmedetomidine, given during general anesthesia, helps keep your heart rate and blood pressure stable during outpatient surgery. It may be an option if you are having a minor surgery and are not on certain heart medications.

Nîmes

Hear when a new Familial Dysautonomia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.